Sun Pharma Q1FY12 Result Update

First Page		Document Content
Date: 2011-08-01 06:08:09 Financial ratios Fundamental analysis Food and drink Valuation Earnings before interest taxes depreciation and amortization Private equity Sun Pharmaceutical Profit margin Pharmaceutical industry in India Business Finance Generally Accepted Accounting Principles		Sun Pharma Q1FY12 Result Update Add to Reading List Source URL: smartinvestor.business-standard.com Download Document from Source Website File Size: 90,51 KB Share Document on Facebook

	70 WAYS TO MAKE YOUR BUSINESS HEALTHIER Running a small business is hard; the cost of business keeps rising, and it seems like the profit margin keeps shrinking. We know you’re always looking for new ways to improve an DocID: 1u2TF - View Document
	Tamr for Sourcing Analytics Tamr for Sourcing Analytics Rapidly Deploy Sourcing Analytics For Complete Visibility Into Your Spend The production of a high-quality product at an attractive profit margin is the lifeblood DocID: 1t6l7 - View Document
	Press Release – 2Q 2008 Results ECS 2Q 2008 NET PROFIT RISES 28.8% TO $8.0M, DRIVEN BY HIGHER-MARGIN STRATEGIES; ON TRACK FOR BETTER YEAR–ON-YEAR 3Q PERFORMANCE DocID: 1t5W1 - View Document
	Press Release – 1Q 2009 Results ECS 1Q 2009 NET PROFIT RISES 17.5% Y-o-Y TO $6.9M DESPITE LOWER REVENUE AND GROSS PROFIT MARGIN EASING TO 4.3% FROM 4.9% • DocID: 1t3wf - View Document
	Press Release – 3Q 2008 Results SGX-LISTED ECS 3Q 2008 NET PROFIT RISES 22.8% TO $7.6M AS NET PROFIT MARGIN AND CASH POSITION IMPROVE • Net profit increases 22.8% to $7.6 million from $6.2 million, lifted by DocID: 1sY7Q - View Document